FDA clears Rosa Shoulder surgical robot from Zimmer Biomet
Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Rosa Shoulder robotic assisted surgery system.
Source: massdevice.com
Stay updated with breaking news from Identity Shoulder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Rosa Shoulder robotic assisted surgery system.
Operator: Good morning, ladies and gentlemen. And welcome to the Zimmer Biomet First Quarter 2023 Earnings Conference Call.